Cannabidiol (Epidyolex®) for severe behavioral manifestations in patients with tuberous sclerosis complex, mucopolysaccharidosis type III and fragile X syndrome: protocol for a series of randomized, placebo-controlled N-of-1 trials.
Saved in:
| Title: | Cannabidiol (Epidyolex®) for severe behavioral manifestations in patients with tuberous sclerosis complex, mucopolysaccharidosis type III and fragile X syndrome: protocol for a series of randomized, placebo-controlled N-of-1 trials. |
|---|---|
| Authors: | Müller, A. R.1,2,3 (AUTHOR), den Hollander, B.1,3,4 (AUTHOR), van de Ven, P. M.5 (AUTHOR), Roes, K. C. B.6 (AUTHOR), Geertjens, L.7,8 (AUTHOR), Bruining, H.3,7,8,9 (AUTHOR), van Karnebeek, C. D. M.1,3,4,10 (AUTHOR), Jansen, F. E.11 (AUTHOR), de Wit, M. C. Y.12,13 (AUTHOR), ten Hoopen, L. W.12,14 (AUTHOR), Rietman, A. B.12,14 (AUTHOR), Dierckx, B.12,14 (AUTHOR), Wijburg, F. A.1 (AUTHOR), Boot, E.2,15,16 (AUTHOR), Brands, M. M. G.1,3,4 (AUTHOR), van Eeghen, A. M.1,2,3 (AUTHOR) a.m.vaneeghen@amsterdamumc.nl |
| Source: | BMC Psychiatry. 1/4/2024, Vol. 24 Issue 1, p1-14. 14p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 174601799 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Cannabidiol (Epidyolex®) for severe behavioral manifestations in patients with tuberous sclerosis complex, mucopolysaccharidosis type III and fragile X syndrome: protocol for a series of randomized, placebo-controlled N-of-1 trials. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Müller%2C+A%2E+R%2E%22">Müller, A. R.</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22den+Hollander%2C+B%2E%22">den Hollander, B.</searchLink><relatesTo>1,3,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22van+de+Ven%2C+P%2E+M%2E%22">van de Ven, P. M.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Roes%2C+K%2E+C%2E+B%2E%22">Roes, K. C. B.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Geertjens%2C+L%2E%22">Geertjens, L.</searchLink><relatesTo>7,8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bruining%2C+H%2E%22">Bruining, H.</searchLink><relatesTo>3,7,8,9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22van+Karnebeek%2C+C%2E+D%2E+M%2E%22">van Karnebeek, C. D. M.</searchLink><relatesTo>1,3,4,10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jansen%2C+F%2E+E%2E%22">Jansen, F. E.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22de+Wit%2C+M%2E+C%2E+Y%2E%22">de Wit, M. C. Y.</searchLink><relatesTo>12,13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22ten+Hoopen%2C+L%2E+W%2E%22">ten Hoopen, L. W.</searchLink><relatesTo>12,14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Rietman%2C+A%2E+B%2E%22">Rietman, A. B.</searchLink><relatesTo>12,14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dierckx%2C+B%2E%22">Dierckx, B.</searchLink><relatesTo>12,14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wijburg%2C+F%2E+A%2E%22">Wijburg, F. A.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Boot%2C+E%2E%22">Boot, E.</searchLink><relatesTo>2,15,16</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Brands%2C+M%2E+M%2E+G%2E%22">Brands, M. M. G.</searchLink><relatesTo>1,3,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22van+Eeghen%2C+A%2E+M%2E%22">van Eeghen, A. M.</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<i> a.m.vaneeghen@amsterdamumc.nl</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22BMC+Psychiatry%22">BMC Psychiatry</searchLink>. 1/4/2024, Vol. 24 Issue 1, p1-14. 14p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=174601799 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s12888-023-05422-3 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 14 StartPage: 1 Titles: – TitleFull: Cannabidiol (Epidyolex®) for severe behavioral manifestations in patients with tuberous sclerosis complex, mucopolysaccharidosis type III and fragile X syndrome: protocol for a series of randomized, placebo-controlled N-of-1 trials. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Müller, A. R. – PersonEntity: Name: NameFull: den Hollander, B. – PersonEntity: Name: NameFull: van de Ven, P. M. – PersonEntity: Name: NameFull: Roes, K. C. B. – PersonEntity: Name: NameFull: Geertjens, L. – PersonEntity: Name: NameFull: Bruining, H. – PersonEntity: Name: NameFull: van Karnebeek, C. D. M. – PersonEntity: Name: NameFull: Jansen, F. E. – PersonEntity: Name: NameFull: de Wit, M. C. Y. – PersonEntity: Name: NameFull: ten Hoopen, L. W. – PersonEntity: Name: NameFull: Rietman, A. B. – PersonEntity: Name: NameFull: Dierckx, B. – PersonEntity: Name: NameFull: Wijburg, F. A. – PersonEntity: Name: NameFull: Boot, E. – PersonEntity: Name: NameFull: Brands, M. M. G. – PersonEntity: Name: NameFull: van Eeghen, A. M. IsPartOfRelationships: – BibEntity: Dates: – D: 04 M: 01 Text: 1/4/2024 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 1471244X Numbering: – Type: volume Value: 24 – Type: issue Value: 1 Titles: – TitleFull: BMC Psychiatry Type: main |
| ResultId | 1 |